Skip to main content
. Author manuscript; available in PMC: 2018 Jun 12.
Published in final edited form as: Mol Pharm. 2016 Nov 7;14(5):1365–1372. doi: 10.1021/acs.molpharmaceut.6b00929

Table 4. Quantitative Determination of Kidney Profile Markers in Lithium-Heparinized Whole Blood from NSG Mice Bearing Orthotopic Pancreatic Tumors after Single Intravenous Injection of Free GEM and mPEG-b-PCC-g-GEM-g-DC (Abbreviated as F-GEM and P-GEM) at GEM Equivalent Dose of 40 mg/kg.

samples

parametersa control F-GEM P-GEM
BUN (mg/dL) 25 ± 0.8 23 ± 3.5 21.7 ± 2.8
GLU (mg/dL) 233 ± 22 209 ± 48 224 ± 21
CRE (mg/dL) 0.2 ± 0.1 0.25 ± 0.1 0.2 ± 0.1
Ca (mg/dL) 10.1 ± 0.2 9.9 ± 0.7 9.6 ± 0.3
PHOS (mg/dL) 8.6 ± 0.3 8.3 ± 1.1 8.9 ± 0.8
Na+ (mmol/L) 144 ± 2.2 150 ± 3 150 ± 1.8
Cl(mmol/L) 105 ± 5.2 109 ± 4.4 107 ± 2.4
K+(mmol/L) 7.4 ± 0.7 8.7 ± 0.4 6.9 ± 0.5
tCO2(mmol/L) 18.7 ± 2.5 20.3 ± 4 17.2 ± 2.5
a

F-GEM, free gemcitabine; P-GEM, mPEG-b-PCC-g-GEM-g-DC; BUN, blood urea nitrogen; GLU, blood glucose; CRE, creatinine; Ca, calcium; PHOS, phosphorus; ALB, albumin; Na+, sodium ion; Cl,chloride ion; K+, potassium ion; tCO2, total carbondioxide. Data are presented as the mean ± SD (n = 4).